Cyclooxygenases: structural and functional insights

被引:501
作者
Rouzer, Carol A.
Marnett, Lawrence J. [1 ]
机构
[1] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Dept Biochem, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
prostaglandin; endocannabinoid; inflammation; nonsteroidal anti-inflammatory; coxib; hydroperoxide; arachidonic acid; essential fatty acid; ENDOPEROXIDE-H SYNTHASE-1; IN-VIVO; COX-2; INHIBITION; INFLAMMATION; MICE; LIPOPOLYSACCHARIDE; OXYGENATION; ACTIVATION; EXPRESSION;
D O I
10.1194/jlr.R800042-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclooxygenase (COX; prostaglandin G/H synthase, EC 1.14.99.1) catalyzes the first two steps in the biosynthesis of prostaglandins (PGs). The two COX isoforms COX-1 and COX-2 are the targets of the widely used nonsteroidal anti-inflammatory drugs, indicating a role for these enzymes in pain, fever, inflammation, and tumorigenesis. The ubiquitous constitutive expression of COX-1 and inducible expression of COX-2 have led to the widely held belief that COX-1 produces homeostatic PGs, while PGs produced by COX-2 are primarily pathophysiological. However, recent discoveries call this paradigm into question and reveal as yet underappreciated functions for both enzymes.jlr This review focuses on some of these new insights.-Rouzer, C. A., and L. J. Marnett. Cyclooxygenases: structural and functional insights. J. Lipid Res. 2009. S29-S34.
引用
收藏
页码:S29 / S34
页数:6
相关论文
共 45 条
[1]   Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2 [J].
Aid, Saba ;
Langenbach, Robert ;
Bosetti, Francesca .
JOURNAL OF NEUROINFLAMMATION, 2008, 5 (1)
[2]   Structural and functional basis of cyclooxygenase inhibition [J].
Blobaum, Anna L. ;
Marnett, Lawrence J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) :1425-1441
[3]   Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury [J].
Choi, Sang Ho ;
Langenbach, Robert ;
Bosetti, Francesca .
FASEB JOURNAL, 2008, 22 (05) :1491-1501
[4]  
Crosby Colin G, 2003, Expert Opin Emerg Drugs, V8, P1
[5]   Evaluation of [11C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation [J].
de Vries, Erik F. J. ;
Doorduin, Janine ;
Dierckx, Rudi A. ;
van Waarde, Aren .
NUCLEAR MEDICINE AND BIOLOGY, 2008, 35 (01) :35-42
[6]   Cyclooxygenase in biology and disease [J].
Dubois, RN ;
Abramson, SB ;
Crofford, L ;
Gupta, RA ;
Simon, LS ;
Van De Putte, LBA ;
Lipsky, PE .
FASEB JOURNAL, 1998, 12 (12) :1063-1073
[7]   BLOOD CONCENTRATION OF NORADRENALINE IN DOG AFTER INTRAVENOUS ADMINISTRATION AND EFFECTS OF DESIPRAMINE [J].
EBLE, JN ;
GOWDEY, CW ;
VANE, JR .
NATURE, 1971, 231 (5299) :181-&
[8]  
Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129
[9]   COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARδ activation [J].
Ghosh, Mallika ;
Wang, Haibin ;
Ai, Youxi ;
Romeo, Elisa ;
Luyendyk, James P. ;
Peters, Jeffrey M. ;
Mackman, Nigel ;
Dey, Sudhansu K. ;
Hla, Timothy .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (09) :2053-2061
[10]   Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities [J].
Grosser, T ;
Fries, S ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :4-15